We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty

By MedImaging International staff writers
Posted on 22 Dec 2009
Targeted breast ultrasound of suspicious areas of the breast, including lumps, is a safe, reliable, and cost-effective alternative to invasive biopsies for women under age 40, according to the recent findings of two studies.

The research was presented December 3, 2009, at the annual meeting of the Radiological Society of North America (RSNA), held in Chicago, IL, USA. "By performing high-quality breast ultrasound, we can reduce the number of expensive and avoidable invasive diagnostic procedures in young women,” said senior author Constance D. Lehman, M.D., Ph.D., professor and vice chair of radiology at the University of Washington (Seattle, WA, USA) and director of imaging at the Seattle Cancer Care Alliance. "We don't want to be overly aggressive with this population.”

The researchers conducted two studies in which targeted ultrasound was used to differentiate between potentially cancerous masses and benign findings in young women who had detected breast lumps or other focal (specific) areas of concern in their breasts. The first study included 1,123 ultrasound examinations of women under age 30, while the second included 1,577 ultrasound examinations of women ages 30 to 39.

Across both studies, all instances of cancer at the site of the clinical concern were positively identified through targeted ultrasound. Moreover, all negative ultrasound findings accurately identified benign changes in the breast. The only malignant tumor not identified by ultrasound was an unsuspected lesion outside of the targeted examination area. That cancer was detected by a full breast mammogram.

The incidence of malignancy among women in their 30s was 2%. The incidence of malignancy among women younger than 30 was 0.4%. "Surgical excision or needle biopsy of tissue can be painful, expensive, and frequently unnecessary in these age groups, which have very low rates of malignancies,” Dr. Lehman said. "In most cases, monitoring with targeted ultrasound is a very safe alternative.” She added that ultrasound should be the diagnostic tool of choice for young women seeking care for breast lumps and other suspicious focal signs and symptoms. "It is time we used ultrasound to reduce unnecessary morbidity and costs associated with more aggressive invasive approaches,” she concluded.

Related Links:

University of Washington


Digital Radiographic System
OMNERA 300M
Digital Color Doppler Ultrasound System
MS22Plus
X-ray Diagnostic System
FDX Visionary-A
Ultrasonic Pocket Doppler
SD1

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.